04 Feb Distribution agreement for the Wound Care line with the Company Integra LifeSciences
Another piece that enriches an important mosaic: the US-based Multinational is a world leader for medical technologies
Headquartered in Princeton, New Jersey, USA, Integra LifeSciences is a leading global provider of regenerative tissue technologies and neurosurgical solutions dedicated to surgeons: this mission becomes a driving force of excellence also for the Rigenera HBW-micrografts technology.
Specifically, the two companies have agreed to distribute the Rigenera Wound Care Line in Italy as of January 1, 2021.
Integra immediately showed considerable appreciation for the Rigenera Technology, which HBW owns, to enrich its product portfolio relating to Tissue Technologies, relating to the treatment of skin lesions (i.e. burns, diabetic lesions, ulcers and difficult wounds): scientific and clinical studies have shown how, in all these cases, the Rigenera technology is able to stimulate the repair of the damaged tissues.
Rigenera Hbw and Integra LifeSciences also share a similar philosophy, since they intend to facilitate the work of surgeons as much as possible, providing professionals with simple-to-use and proven effective tools, for their satisfaction and for patients.
Therefore, the agreement adds another important piece to a mosaic that is growing every day and which, today, sees Rigenera Hbw technology distributed in over 40 countries around the world.
“SHRO are extremely pleased – comments Antonio Graziano, CEO of Rigenera Hbw – of starting this partnership with a multinational leader in the field. We are proud of this agreement that will further strengthen our presence in the regenerative medicine field.
We believe that Integra is the right strategic partner to start 2021 in the best possible way by continuing to constantly implement our expansion into new markets and always remaining an extremely dynamic and innovative company.